Becton Dickinson

Philips spends big in-house while Becton favours buying
Philips spends big in-house while Becton favours buying
EP Vantage
devices
R&D
Philips
Becton Dickinson
Flag link:
FDA Authorizes Becton, Dickinson Portable 15-Minute Coronavirus Test
FDA Authorizes Becton, Dickinson Portable 15-Minute Coronavirus Test
Motley Fool
FDA
Becton Dickinson
diagnostics
Emergency Use Authorization
pandemic
COVID-19
Flag link:
There's a New 15-Minute Coronavirus Test
There's a New 15-Minute Coronavirus Test
Motley Fool
Becton Dickinson
BioMedomics
coronaviruses
COVID-19
diagnostics
Flag link:
Becton Dickinson out for blood with new partnership
Becton Dickinson out for blood with new partnership
EP Vantage
diagnostics
Becton Dickinson
blood testing
Babson Diagnostics
Flag link:
10 Events in Medtech That We Didn’t See Coming This Year
10 Events in Medtech That We Didn’t See Coming This Year
Medical Devices and Diagnostics Industry
devices
Edwards Lifesciences
Boston Scientific
Thrive Earlier Detection
Obalon
Alcon
Abbott Labs
Theranos
JNJ
robotic surgery
Becton Dickinson
FDA
sterlization
Scott Gottlieb
Flag link:
BD launches second-gen ergonomic injection pen
BD launches second-gen ergonomic injection pen
Drug Delivery Business News
Becton Dickinson
BD Nano pen
devices
drug delivery
Flag link:
Becton Dickinson’s fiscal Q1 prelims beat The Street
Becton Dickinson’s fiscal Q1 prelims beat The Street
Mass Device
Becton Dickinson
earnings
devices
Flag link:
Becton Dickinson’s Q4 meets earnings expectations, beats on revenue
Becton Dickinson’s Q4 meets earnings expectations, beats on revenue
Mass Device
earnings
Becton Dickinson
devices
Flag link:
Roche leaves Abbott in the dust when it comes to US approval times
Roche leaves Abbott in the dust when it comes to US approval times
EP Vantage
devices
FDA
device approvals
Roche
Abbott Labs
Becton Dickinson
Flag link:
Appeals court overturns patent board in Bard spat with AngioDynamics
Appeals court overturns patent board in Bard spat with AngioDynamics
Mass Device
devices
CR Bard
Becton Dickinson
AngioDynamics
patents
Flag link:
Becton, Dickinson Sees Synergies From Bard With More to Come
Becton, Dickinson Sees Synergies From Bard With More to Come
Motley Fool
devices
earnings
Becton Dickinson
CR Bard
Flag link:
New Jersey jury hits BD subsidiary Bard with $33m pelvic mesh verdict
New Jersey jury hits BD subsidiary Bard with $33m pelvic mesh verdict
Mass Device
Becton Dickinson
C.R. Bard
pelvic mesh
Bard Avaulta vaginal sling
Align
New Jersey
Flag link:
Merit Medical to pay $100m for Bard, BD biopsy assets
Merit Medical to pay $100m for Bard, BD biopsy assets
Mass Device
Merit Medical
devices
CR Bard
Becton Dickinson
M&A
Flag link:
Becton, Dickinson beats The Street with Q4, 2017 numbers
Becton, Dickinson beats The Street with Q4, 2017 numbers
Mass Device
Becton Dickinson
earnings
devices
Flag link:
Becton Dickinson blood tubes under investigation in FDA probe of faulty lead tests
Becton Dickinson blood tubes under investigation in FDA probe of faulty lead tests
Mass Device
Becton Dickinson
devices
FDA
Magellan Diagnostics
Flag link:
Bard shareholders approve $24B merger with BD
Bard shareholders approve $24B merger with BD
Mass Device
CR Bard
Becton Dickinson
M&A
devices
Flag link:
Medtech M&A: The 10 biggest deals so far in 2017
Medtech M&A: The 10 biggest deals so far in 2017
Mass Device
devices
M&A
Abbott Labs
St. Jude Medical
Edwards Lifesciences
Valtech Cardio
Hologic
Cynosure
JNJ
Teleflex
Vascular Soltions
Cardinal Health
Medtronic
Becton Dickinson
CR Bard
Boston Scientific
Symetis
Integra LifeSciences
Codman Neuro
Stryker
Novadaq
Flag link:
Becton Dickinson to acquire Bard in $24B deal
Becton Dickinson to acquire Bard in $24B deal
Mass Device
Becton Dickinson
CR Bard
devices
M&A
Flag link:
Becton, Dickinson: Road Map Into The Future
Becton, Dickinson: Road Map Into The Future
Seeking Alpha
Becton Dickinson
Flag link:
Inside Becton Dickinson’s Biggest Growth Driver
Inside Becton Dickinson’s Biggest Growth Driver
Yahoo/Market Realist
Becton Dickinson
Flag link:

Pages